Bernard Y. Cheung

102 Pokfulam Road
Hong Kong, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 212 publications

Correction: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study.

Correction: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: August 31, 2026

Age-Associated Patterns of Cardiovascular Risk and Disease Phenotypes Across Diverse Care Settings: The GLOB-cAGE Consortium.

Age-Associated Patterns of Cardiovascular Risk and Disease Phenotypes Across Diverse Care Settings: The GLOB-cAGE Consortium.

Journal: American journal of physiology. Heart and circulatory physiology

Published: August 08, 2026

Response to letter regarding [Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study].

Response to letter regarding [Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study].

Journal: Annals of medicine

Published: November 24, 2025

Postgraduate Medical Journal, the early years.

Postgraduate Medical Journal, the early years.

Journal: Postgraduate medical journal

Published: October 29, 2025

Interpretable multimodal machine learning model for predicting health risks of patients with heart failure.

Interpretable multimodal machine learning model for predicting health risks of patients with heart failure.

Journal: Methods (San Diego, Calif.)

Published: October 09, 2025

Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation.

Trimetazidine Is Associated With Ameliorated Stroke Risk in Patients With Both Ischemic Heart Disease and Atrial Fibrillation.

Journal: Journal of the American Heart Association

Published: September 30, 2025

GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials.

GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials.

Journal: Diabetes care

Published: August 06, 2025

The impact of the Lancet Commission definition of obesity on its prevalence and implications on long-term cardiovascular-kidney-metabolic outcomes in East Asians: Observational study of two community-based cohorts.

The impact of the Lancet Commission definition of obesity on its prevalence and implications on long-term cardiovascular-kidney-metabolic outcomes in East Asians: Observational study of two community-based cohorts.

Journal: PLoS medicine

Published: July 17, 2025

Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation.

Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients With Infective Endocarditis: A Target Trial Emulation.

Journal: Journal of the American Heart Association

Published: July 17, 2025

Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes.

Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes.

Journal: Metabolism: clinical and experimental

Published: July 04, 2025

Impact of digoxin versus beta-blocker in patients with coexistent atrial fibrillation and heart failure: a target trial emulation.

Impact of digoxin versus beta-blocker in patients with coexistent atrial fibrillation and heart failure: a target trial emulation.

Journal: BMC medicine

Published: June 25, 2025

Comparison of New-Onset Peripheral Artery Disease in Patients With Type 2 Diabetes Exposed to Sodium-Glucose Cotransporter-2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, or Glucagon-Like Peptide-1 Agonists: A Population-Based Cohort Study.

Comparison of New-Onset Peripheral Artery Disease in Patients With Type 2 Diabetes Exposed to Sodium-Glucose Cotransporter-2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, or Glucagon-Like Peptide-1 Agonists: A Population-Based Cohort Study.

Journal: Journal of the American Heart Association

Published: May 22, 2025

Showing 1-12 of 212

Last Updated: 09/26/2026